The Impact of High Dietary Sodium Consumption on Blood Pressure Variability in Healthy, Young Adults.
blood pressure
blood pressure variability
central blood pressure variability
hypertension
salt
Journal
American journal of hypertension
ISSN: 1941-7225
Titre abrégé: Am J Hypertens
Pays: United States
ID NLM: 8803676
Informations de publication
Date de publication:
29 04 2020
29 04 2020
Historique:
received:
30
10
2019
revised:
06
01
2020
accepted:
31
01
2020
pubmed:
2
2
2020
medline:
22
12
2020
entrez:
2
2
2020
Statut:
ppublish
Résumé
High sodium (Na+) intake augments blood pressure variability (BPV) in normotensive rodents, without changes in resting blood pressure (BP). Augmented BPV is associated with end-organ damage and cardiovascular morbidity. It is unknown if changes in dietary Na+ influence BPV in humans. We tested the hypothesis that high Na+ feeding would augment BPV in healthy adults. Twenty-one participants (10 F/11 M; 26 ± 5 years; BP: 113 ± 11/62 ± 7 mm Hg) underwent a randomized, controlled feeding study that consisted of 10 days of low (2.6 g/day), medium (6.0 g/day), and high (18.0 g/day) salt diets. On the ninth day of each diet, 24-h urine samples were collected and BPV was calculated from 24-h ambulatory BP monitoring. On the tenth day, in-laboratory beat-to-beat BPV was calculated during 10 min of rest. Serum electrolytes were assessed. We calculated average real variability (ARV) and standard deviation (SD) as metrics of BPV. As a secondary analysis, we calculated central BPV from the 24-h ambulatory BP monitoring. 24-h urinary Na+ excretion (low = 41 ± 24, medium = 97 ± 43, high = 265 ± 92 mmol/24 h, P < 0.01) and serum Na+ (low = 140.0 ± 2.1, medium = 140.7 ± 2.7, high = 141.7 ± 2.5 mmol/l, P = 0.009) increased with greater salt intake. 24-h ambulatory ARV (systolic BP ARV: low = 9.5 ± 1.7, medium = 9.5 ± 1.2, high = 10.0 ± 1.9 mm Hg, P = 0.37) and beat-to-beat ARV (systolic BP ARV: low = 2.1 ± 0.6, medium = 2.0 ± 0.4, high = 2.2 ± 0.8 mm Hg, P = 0.46) were not different. 24-h ambulatory SD (systolic BP: P = 0.29) and beat-to-beat SD (systolic BP: P = 0.47) were not different. There was a trend for a main effect of the diet (P = 0.08) for 24-h ambulatory central systolic BPV. Ten days of high sodium feeding does not augment peripheral BPV in healthy, adults. NCT02881515.
Sections du résumé
BACKGROUND
High sodium (Na+) intake augments blood pressure variability (BPV) in normotensive rodents, without changes in resting blood pressure (BP). Augmented BPV is associated with end-organ damage and cardiovascular morbidity. It is unknown if changes in dietary Na+ influence BPV in humans. We tested the hypothesis that high Na+ feeding would augment BPV in healthy adults.
METHODS
Twenty-one participants (10 F/11 M; 26 ± 5 years; BP: 113 ± 11/62 ± 7 mm Hg) underwent a randomized, controlled feeding study that consisted of 10 days of low (2.6 g/day), medium (6.0 g/day), and high (18.0 g/day) salt diets. On the ninth day of each diet, 24-h urine samples were collected and BPV was calculated from 24-h ambulatory BP monitoring. On the tenth day, in-laboratory beat-to-beat BPV was calculated during 10 min of rest. Serum electrolytes were assessed. We calculated average real variability (ARV) and standard deviation (SD) as metrics of BPV. As a secondary analysis, we calculated central BPV from the 24-h ambulatory BP monitoring.
RESULTS
24-h urinary Na+ excretion (low = 41 ± 24, medium = 97 ± 43, high = 265 ± 92 mmol/24 h, P < 0.01) and serum Na+ (low = 140.0 ± 2.1, medium = 140.7 ± 2.7, high = 141.7 ± 2.5 mmol/l, P = 0.009) increased with greater salt intake. 24-h ambulatory ARV (systolic BP ARV: low = 9.5 ± 1.7, medium = 9.5 ± 1.2, high = 10.0 ± 1.9 mm Hg, P = 0.37) and beat-to-beat ARV (systolic BP ARV: low = 2.1 ± 0.6, medium = 2.0 ± 0.4, high = 2.2 ± 0.8 mm Hg, P = 0.46) were not different. 24-h ambulatory SD (systolic BP: P = 0.29) and beat-to-beat SD (systolic BP: P = 0.47) were not different. There was a trend for a main effect of the diet (P = 0.08) for 24-h ambulatory central systolic BPV.
CONCLUSIONS
Ten days of high sodium feeding does not augment peripheral BPV in healthy, adults.
CLINICAL TRIALS REGISTRATION
NCT02881515.
Identifiants
pubmed: 32006422
pii: 5719606
doi: 10.1093/ajh/hpaa014
pmc: PMC7188796
doi:
Substances chimiques
Sodium Chloride, Dietary
0
Banques de données
ClinicalTrials.gov
['NCT02881515']
Types de publication
Comparative Study
Journal Article
Randomized Controlled Trial
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
422-429Subventions
Organisme : NHLBI NIH HHS
ID : K01 HL147998
Pays : United States
Organisme : NIGMS NIH HHS
ID : P20 GM113125
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL128388
Pays : United States
Commentaires et corrections
Type : CommentIn
Informations de copyright
© American Journal of Hypertension, Ltd 2020. All rights reserved. For Permissions, please email: journals.permissions@oup.com.
Références
Am J Physiol Regul Integr Comp Physiol. 2018 Oct 1;315(4):R688-R695
pubmed: 29949407
J Hum Hypertens. 2017 Feb;31(2):145-150
pubmed: 27511475
Hypertension. 2000 Nov;36(5):901-6
pubmed: 11082164
Am J Hypertens. 2007 Feb;20(2):154-61
pubmed: 17261460
Pulse (Basel). 2017 Jan;4(4):180-192
pubmed: 28229053
Blood Press Monit. 2007 Apr;12(2):113-7
pubmed: 17353655
Am J Physiol Heart Circ Physiol. 2007 Oct;293(4):H2313-9
pubmed: 17644564
Am J Physiol Heart Circ Physiol. 2018 Aug 1;315(2):H303-H313
pubmed: 30028200
J Neurophysiol. 2018 Apr 1;119(4):1257-1265
pubmed: 29357474
PLoS One. 2016 Jan 05;11(1):e0144921
pubmed: 26731185
J Hypertens. 2005 Mar;23(3):505-11
pubmed: 15716690
Hypertension. 2007 Jul;50(1):197-203
pubmed: 17485598
J Hypertens. 2007 Oct;25(10):2058-66
pubmed: 17885548
Nutr Metab Cardiovasc Dis. 2014 Sep;24(9):990-5
pubmed: 24989702
Nefrologia. 2016 Nov - Dec;36(6):694-700
pubmed: 27210544
J Am Soc Hypertens. 2017 Oct;11(10):627-634
pubmed: 28830669
Hypertension. 2001 May;37(5):1199-208
pubmed: 11358929
Blood Press Monit. 1996 Feb;1(1):3-11
pubmed: 10226196
BMJ. 2000 Apr 22;320(7242):1128-34
pubmed: 10775227
Hypertension. 2014 Sep;64(3):583-9
pubmed: 24914195
Circulation. 2000 Sep 26;102(13):1536-41
pubmed: 11004145
Exp Physiol. 2016 Mar;101(3):449-50
pubmed: 27511604
Nat Rev Cardiol. 2013 Mar;10(3):143-55
pubmed: 23399972
J Clin Hypertens (Greenwich). 2018 Feb;20(2):266-272
pubmed: 29370469
Circulation. 2005 Feb 8;111(5):697-716
pubmed: 15699287
Hypertension. 2014 Apr;63(4):790-6
pubmed: 24396027
BMJ. 2009 Nov 24;339:b4567
pubmed: 19934192
J Am Diet Assoc. 2005 May;105(5):775-89
pubmed: 15883556
Hypertension. 2007 Aug;50(2):354-9
pubmed: 17592069
J Hypertens. 2013 Mar;31(3):530-6
pubmed: 23263240
Curr Opin Nephrol Hypertens. 2013 Jan;22(1):59-64
pubmed: 23165110
J Hum Hypertens. 2017 Oct;31(10):633-639
pubmed: 28569260
Eur Heart J. 2014 Jul;35(26):1719-25
pubmed: 24459197
J Am Coll Cardiol. 2018 May 15;71(19):e127-e248
pubmed: 29146535
Blood Press. 2015 Apr;24(2):124-9
pubmed: 25555153
J Physiol. 2012 Nov 1;590(21):5519-28
pubmed: 22907057
J Hypertens Suppl. 1994 Nov;12(8):S29-33
pubmed: 7707152